This contract expires in 64 days (Aug 9, 2026).
MCKESSON CORPORATION - B1 MCKESSON REGULAR MEDICATION FY26 DELIVERY ORDER AGAINST 36W79720D0001 CONTRACT PERIOD IS 08/10/2024 TO 08/9/2026, FOR PHARMACEUTICALS AT FDC HOUSTON FOR FY 26. *PRIOR KNOWLEDGE OF THIS MEDICAL SERVICES IS APPROVED AND JUSTIFIED BY HSA AND SCS*
Key Details
Description
B1 MCKESSON REGULAR MEDICATION FY26 DELIVERY ORDER AGAINST 36W79720D0001 CONTRACT PERIOD IS 08/10/2024 TO 08/9/2026, FOR PHARMACEUTICALS AT FDC HOUSTON FOR FY 26. *PRIOR KNOWLEDGE OF THIS MEDICAL SERVICES IS APPROVED AND JUSTIFIED BY HSA AND SCS*
Context & Analysis
On Dec 8, 2025, Department of Justice obligated $61,018.53 to MCKESSON CORPORATION for b1 mckesson regular medication fy26 delivery order against 36w79720d0001 contract period is 08/10/2024 to 08/9/2026, for pharmaceuticals at fdc houston for fy 26. *prior knowledge of this medical ser…. The award is classified under NAICS 325412 — PHARMACEUTICAL PREPARATION MANUFACTURING and issued as a firm fixed price contract. Competition extent: full and open competition. Performance is located in IRVING, TX. The contract is scheduled through Aug 9, 2026 — approximately 2 months remaining. This award is one of several similar procurements from Department of Justice under NAICS 325412 — related awards are listed below.
Contractor Information
Similar Awards
MCKESSON NON-CONTROLLED DOS: NOV 1- CR MARCH 14, 2024
MCKESSON CORPORATION
$29.2M
MCKESSON: NON-CONTROLLED MEDICATION DOS: OCTOBER 1, 2025 THRU DECEMBER 31, 2025.
MCKESSON CORPORATION
$10.0M
PPV PHARMACEUTICAL ITEMS - FISCAL YEAR 25 PROCUREMENT OF PHARMACEUTICALS ON THE PPV
MCKESSON CORPORATION
$5.3M
MCKESSON STANDARD MEDICATION FY 2025
MCKESSON CORPORATION
$4.4M
MCKESSON STANDARD MEDICATION FY 2025
MCKESSON CORPORATION
$4.4M
Stay Updated
Get notified about new opportunities matching your interests.